Professor Sarah Larney

Co-Head, Alcohol and Other Drugs

Working groups

Alcohol and Other Drugs group

sarah.larney@burnet.edu.au

Background

Professor Sarah Larney's research focuses on the epidemiology and prevention of drug-related harms, particularly blood-borne viral infections and overdose. Prior to her appointment as co-head of the Alcohol and Other Drugs working group at Burnet, she was an Associate Professor in the Department of Family Medicine and Emergency Medicine at the Université de Montréal and Principal Researcher at the Centre de recherche du Centre hospitalier de l'Université de Montréal.

Sarah's contributions to the field include findings related to drug use and treatment of opioid dependence among older adults; work documenting the onset of Canada's overdose epidemic in Québec (delayed relative to the rest of Canada); and novel findings relating to sex and gender differences in hepatitis C among people who inject drugs. Her work has influenced opioid treatment delivery in Australia, the United States and Canada.

Qualifications

2011: PhD, University of New South Wales, Australia
2003: Bachelor of Arts/Bachelor of Science (Honours), University of New South Wales, Australia

Burnet publications

07 Dec 2020

Initiation of Medications for Opioid Use Disorder Shortly Before Release From Prison to Promote Treatment Retention: Strong Evidence but Compromised Policy

Journal of Addiction Medicine

M. David Curtis et al

Current projects

Substance use support for women moving in and out of prison (SUSTain)

We’re delivering alcohol and other drugs transitional care for women leaving prison – codesigned with those who know it best.

Unlocking health: using linked administrative data to improve health outcomes for people incarcerated in Victoria

In this project we aim to establish a system for monitoring health and health service use among people leaving prison in Victoria.